Evidence explainer

Evidence and research methods

What Makes Science Communication Trustworthy

Trustworthy science communication lets you reconstruct the claim yourself: what was studied, how big the effect was, how uncertain it is, and who paid for it.

Fully reviewed by Jasaman (Jasmin) Tojjar, MD, PhD

On this page
  1. Begin with an exact claim
  2. Build a source chain readers can follow
  3. Separate data, interpretation, and recommendation
  4. Match verbs to study design
  5. Magnitude needs a denominator
  6. Uncertainty is information
  7. Statistical significance is not a verdict
  8. The broader evidence matters
  9. Funding and interests need context
  10. Distinguish education from promotion
  11. Accessibility improves accuracy
  12. Public-health communication has special demands
  13. AI-assisted content still needs accountable authorship
  14. Corrections demonstrate reliability
  15. A two-minute appraisal
  16. Trust is earned in the details
  17. Sources

Trustworthy science communication does not ask you to accept authority on tone alone. It gives you enough to see what was studied, what was found, how uncertain the estimate is, and where the interpretation starts. A strong explanation remains useful when a result is less exciting than the headline.

Trust is not created by adding more jargon or more citations. It is created by alignment: the words match the evidence, the links support the words, the caveats match the design, and the correction process matches the possibility of error.

This article is a framework for reading and writing science and health information. It does not decide any individual's diagnosis or treatment. Personal decisions require qualified care that can account for the full clinical context.

Begin with an exact claim#

“A study shows exercise helps” is too broad to appraise. Which form of activity, compared with what, in whom, over what duration, for which outcome, and by how much? Trustworthy communication turns a vague message into a bounded statement.

An exact claim might say that a randomized trial in adults with a defined condition compared a supervised program with usual care for 12 weeks and found a specified average change in a validated symptom scale. That sentence gives you something to hold on to.

Precision also prevents scope drift. A short-term change in a laboratory marker does not establish fewer deaths. An association in one cohort does not show that an intervention will help. A mouse mechanism does not establish a human dose. Write the claim before selecting the headline. Otherwise, the headline can become a promise that the body later struggles to defend.

Build a source chain readers can follow#

The most direct source for a new trial is the full report. It is supplemented by its registry, protocol, analysis plan, and regulatory materials when relevant. A press release can guide readers to the study but is not a substitute for it. A news story about another news story increases the chance that qualifications disappear.

Links should point to the exact document supporting the sentence. “Studies show” without a citation is not traceability. A long reference list does not help when none of its entries supports the central number.

Source hierarchy depends on the question, and a systematic review may best summarize treatment evidence, while an official statute is best for the law and a product label is best for an authorized indication. A patient anecdote can explain lived experience but cannot estimate average efficacy. Include the date and the version too, because guidance, labels, datasets, and webpages change.

Separate data, interpretation, and recommendation#

Data are recorded observations. Analysis transforms them into estimates under methods and assumptions. Interpretation explains what those estimates may mean. A recommendation adds values, harms, resources, feasibility, and priorities.

Communication becomes misleading when these layers collapse. “The marker fell by 10 percent” is a result. “The intervention repairs metabolism” is a mechanistic interpretation. “Everyone should use it” is a recommendation. The latter two need evidence beyond the first.

Label exploratory analyses, subgroup findings, and post hoc hypotheses. Describe the authors' explanation as an explanation, not as a fact established by the design. When experts disagree, state which part is disputed and why, and the test is whether you can still tell, by the end, what the study observed and what the person writing about it inferred.

Match verbs to study design#

Random assignment can support causal claims about an intervention when conduct, adherence, missing data, and analysis are credible. Observational studies can identify associations, prognosis, rare harms, and real-world patterns but require assumptions about confounding and selection.

Diagnostic-accuracy studies estimate classification against a reference standard. They do not show that using the test improves outcomes. Prediction models estimate risk; they do not necessarily identify causes. Mendelian randomization strengthens some causal inferences but depends on genetic-instrument assumptions.

Cell and animal experiments help establish mechanisms and safety questions. Translation to humans requires evidence about dose, biology, and clinical outcomes. Use “was associated with,” “predicted,” “reduced in this trial,” or “supports a mechanism” when those phrases fit. Avoid “proves” unless the proposition and evidence genuinely warrant it.

Magnitude needs a denominator#

A 50 percent relative reduction can mean risk fell from 40 percent to 20 percent or from 0.02 percent to 0.01 percent. Both calculations are correct; their practical meaning differs.

Report event counts or absolute risks in each group, the absolute difference, relative measure, and time horizon. Number needed to treat can help when derived from a stable absolute effect, but it must include outcome and duration.

For continuous outcomes, give the scale, direction, and average change. Give the interval and a benchmark for meaningfulness. A statistically significant two-point change can be trivial or important depending on the instrument.

Denominators matter for harms too. “Rare” should be quantified when data allow. If a trial was too small or short to estimate an important harm, say so.

Uncertainty is information#

Confidence intervals describe precision under the model and data. They do not capture every source of bias, measurement error, or missing evidence. Still, they are more informative than a p-value alone.

A result compatible with substantial benefit, no important difference, and harm is uncertain even if the point estimate looks favorable; a narrow interval around a trivial effect can be precise without being important.

Communicators should distinguish uncertainty about the estimate, uncertainty about bias, and uncertainty about application to another population. Language such as “probably,” “may,” and “evidence is insufficient” should be tied to reasons rather than sprinkled as legal protection. Visuals should show intervals and denominators. Truncated axes, icon arrays with hidden baselines, and cumulative curves without numbers can distort perception.

Statistical significance is not a verdict#

The conventional 0.05 threshold does not separate true from false or important from unimportant. Results on either side can be nearly identical. Multiple testing and flexible analysis can produce nominally significant findings by chance.

Report effect estimates, intervals, prespecified outcomes, sample size, and the number of analyses considered. If adjustment for multiplicity was used, explain its purpose. A nonsignificant result is not proof of equivalence unless the design tested an appropriate margin with adequate precision.

Bayesian analyses require priors and model assumptions. Machine-learning performance requires test-set separation and external validation. Every method has quantities that need interpretation. The communication goal is not to teach a full statistics course. It is to prevent one threshold from carrying a conclusion it cannot support.

The broader evidence matters#

One study updates a body of knowledge. It rarely replaces it. Compare the result with prior trials, systematic reviews, guidelines, and plausible mechanisms. State whether it confirms, narrows, contradicts, or extends them.

Replication and independent evidence deserve more weight than novelty alone. A result can differ because of population, intervention, or comparator. It can differ because of outcome, follow-up, bias, or chance. “Scientists were wrong” is often a poor description of normal updating.

Systematic reviews can also be outdated or biased. Check search dates, eligibility, risk-of-bias assessment, heterogeneity, and publication bias. A pooled number is not automatically more credible than its inputs. When evidence conflicts, map the differences. Do not choose the preferred study because its conclusion is convenient.

Funding and interests need context#

Funding can influence which questions are studied, which comparators are chosen, how results are framed, and whether findings are published. Author employment, consulting, and patents may also be relevant. So may equity, advocacy roles, and intellectual commitments.

Disclosure is not an accusation. A commercially funded study can be rigorous, and an unfunded commentary can be biased; you need the information so that you can weigh the incentives alongside the methods and the replication.

State the funder's role in design, data access, analysis, publication, and writing. A generic declaration that “no conflict affected the work” does not replace specific facts. Product endorsements and paid testimonials are also subject to consumer-protection standards. The FTC expects health-related advertising claims to be truthful, not misleading, and supported by appropriate evidence.

Distinguish education from promotion#

Educational format does not neutralize a sales purpose. A page can look like a neutral explainer while directing every uncertainty toward one product. Red flags include selective citation, absence of harms, and comparisons with no credible alternative. They include urgency and undisclosed commercial links.

Claims should be assessed by the overall impression, not only literal wording. A disclaimer cannot cure a page whose images, testimonials, and headings imply a benefit the evidence does not support.

Balanced communication states who should not use a product, what is unknown, what alternatives exist, and whether the evidence tested the exact formulation and dose being sold. Where education and promotion sit on the same page, they should be labeled as what they are, and the editorial decisions should not be taking direction from the sales figures.

Accessibility improves accuracy#

Plain language is not simplification into inaccuracy. It uses familiar words, defines technical terms, places the main point first, and keeps necessary qualifiers attached to the claim.

The CDC Clear Communication Index prompts writers to identify the main message, behavioral recommendation when present, and numbers. It also prompts them to identify risk and audience. Materials should also support screen readers, captions, keyboard access, adequate contrast, and non-color cues.

Translation needs subject expertise and user testing. Numeracy, language, disability, culture, and stress affect how risk is understood. Use several formats, such as absolute counts plus a well-labeled visual, without presenting conflicting frames. The only way to know whether the meaning survived is to ask a reader to say the main claim and its limits back to you, and a readability score cannot tell you that.

Public-health communication has special demands#

During an emergency, evidence changes while people need action. WHO guidance emphasizes trust, transparency, listening, community participation, and timely communication. Waiting for perfect certainty can cause harm; overstating preliminary conclusions can also damage trust.

State what is known now, what action is recommended, and why. State what is unknown and when the next update will occur. Correct rumors without repeating sensational details more than necessary. Coordinate sources so differences in recommendations are explained rather than hidden.

Changes should be framed as evidence updating, with the prior basis and new evidence visible. Pretending advice never changed makes the public record easy to disprove. And do not blame groups or let a risk factor stand in for an identity.

AI-assisted content still needs accountable authorship#

Generative systems can summarize, translate, and draft quickly. They can also invent citations, merge studies, omit decisive qualifiers, and reproduce outdated claims. Fluency is not verification.

Accountable humans should define scope, verify every material claim against primary sources, and check numbers and links. They should review for bias and privacy and approve the final version. AI assistance should be disclosed according to editorial policy and applicable norms; a model cannot accept authorship responsibility.

Versioned prompts or logs may support internal audit where privacy and security permit. Sensitive patient or proprietary data should not be entered into unauthorized tools. Scale is where this gets dangerous: a site that publishes a thousand pages has not thereby shown that any one of them adds value or was ever read by a person.

Corrections demonstrate reliability#

Errors are inevitable in a living evidence system. Trustworthy publishers make correction easy to request, assess it promptly, and preserve a visible record.

A correction note should state what changed, when, and why. Material changes to the conclusion deserve more prominence than typographical fixes. Retractions, expressions of concern, guideline updates, and regulatory actions should propagate to dependent content.

Silently replacing text can mislead readers who cited the earlier version. Version dates, archived copies, and structured change logs preserve provenance, and the policy should reach the social posts, the newsletters, the charts, and the translated editions, not only the canonical webpage.

A two-minute appraisal#

Restate the exact claim. Open the original source and confirm it exists. Identify study design, population, comparator, outcome, and time. Find the absolute numbers and confidence interval. Check whether the headline preserves the paper's limitations.

Look for harms, missing outcomes, registration, and conflicts. Compare with broader evidence and current guidance. Ask whether the exact product, dose, population, and outcome match what is being promoted.

Finally, inspect the publisher's correction process and date. If the claim has changed since publication, current readers need current evidence. None of this amounts to a systematic review, but it catches many of the common failures before you share something.

Trust is earned in the details#

Trustworthy science communication is neither constant skepticism nor automatic confidence. It is a transparent path from evidence to words. You can see the source, the magnitude, and the uncertainty. You can see the incentives and the limits. And you can update when better evidence arrives.

The most credible communicator is not the one who always sounds certain. It is the one whose degree of certainty remains proportional to what the evidence can carry.

Sources#

The metadata sources combine National Academies methods, FTC health-claim standards, CDC clear communication, WHO risk communication, ICMJE disclosure, and CONSORT 2025 reporting guidance.

Sources and further reading

  1. National Academies, Communicating Science Effectively
  2. FTC Health Products Compliance Guidance
  3. CDC Clear Communication Index
  4. WHO Communicating Risk in Public Health Emergencies
  5. ICMJE Disclosure of Financial and Non-Financial Relationships and Activities
  6. CONSORT 2025 Statement

Questions and answers

Does trustworthy communication avoid all uncertainty?

No. It identifies what is known, how precisely it is known, what assumptions matter, and what could change the conclusion. False certainty is less trustworthy than bounded uncertainty.

Is linking to one scientific paper enough?

Not usually. The link should support the exact claim, and readers still need study design, population, comparator, effect size, limitations, conflicts, and the relationship to the broader evidence.

Does a conflict of interest make a claim false?

No. A relevant interest is context for appraisal, not automatic disproof. Disclosure allows readers to evaluate incentives alongside methods, data, replication, and independent evidence.

How should relative risk be communicated?

Give the absolute risks, time horizon, baseline population, and uncertainty alongside the relative comparison so readers can judge practical magnitude.

What is the fastest credibility check for a health claim?

Find the original source, restate the exact population and outcome, identify study design, inspect absolute effect and interval, check harms and limitations, disclose incentives, and compare with the total evidence.